Cidara is pursuing a balanced infectious disease-focused development strategy intended to transform standards of care and save lives

CD101 IV

Candidemia / Invasive Candidiasis

CD201

Multi-Drug Resistant Gram-negative Bacteria

GET IMPORTANT NEWS AND UPDATES BY EMAIL